Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03444662 · ClinicalTrials.gov registry record · NA
The Combination Effect of Citicoline and Omega-3
A NA study, sponsored by Kyowa Hakko Bio Co..
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03444662: Completed NA study, sponsored by Kyowa Hakko Bio Co..
NCT03444662 is a NA study that has completed, run by Kyowa Hakko Bio Co.. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03444662, a NA study, has completed, sponsored by Kyowa Hakko Bio Co..
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The goal of this study is to determine the effects of Citicoline plus Omega-3 or Omega-3 alone versus placebo on attention in non-demented healthy older adults.
Interventions
- DIETARY_SUPPLEMENT Placebo supplement
- DIETARY_SUPPLEMENT Citicoline and Omega-3 supplement
- DIETARY_SUPPLEMENT Omega-3 supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-06-12 |
| Est. Completion | 2019-09-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03444662
The ClinicalTrials.gov registry entry for NCT03444662 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Hakko Bio Co., which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo supplement is the first listed.
NCT03444662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03444662 about?
NCT03444662 is a clinical study titled "The Combination Effect of Citicoline and Omega-3". The goal of this study is to determine the effects of Citicoline plus Omega-3 or Omega-3 alone versus placebo on attention in non-demented healthy older adults.
What is the current status of trial NCT03444662?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-06-12. Estimated completion is 2019-09-03.
What interventions are being tested in trial NCT03444662?
The interventions under investigation include: Placebo supplement (DIETARY_SUPPLEMENT), Citicoline and Omega-3 supplement (DIETARY_SUPPLEMENT), Omega-3 supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03444662?
This trial is sponsored by Kyowa Hakko Bio Co., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.